Results 331 to 340 of about 10,512,482 (403)

Upadacitinib for the Treatment of Upper Gastrointestinal Crohn's Disease. [PDF]

ACG Case Rep J
AlBader B, Jairath R, Baitalmal H, Bessissow T.   +3 more
europepmc   +1 more source

Oncogene deregulation and proliferative activity during exacerbation of disease in Crohn's Disease.

Shahan Mamoor
openalex   +1 more source

A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser, Martijn. A. Oude Voshaar, Reinier C. A. van Linschoten, Alexander G. L. Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K. Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C. Janneke van der Woude, R. L. West, D. van Noord   +12 more
wiley   +1 more source

Viewpoint: The Use of Antimycobacterial (Anti-MAP) Therapies in the Treatment of Active Luminal Crohn's Disease. [PDF]

JGH Open
Pavli P, Gibson PR.
europepmc   +1 more source

Sclerosing cholangitis: Liver transplantation [PDF]

, 1989
Marsh, JW, Starzl, TE
core  

Ubiquitin and a cellular degeneration phenotype in Crohn's Disease.

Shahan Mamoor
openalex   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

A Not-So-Sweet Crohn's Disease: A Case Report of Ileocecal Crohn's Disease Unmasked by Sweet Syndrome. [PDF]

Case Rep Med
Omar A, Salameh R, Karam K, Khoury C, Fiani E.   +4 more
europepmc   +1 more source

The potential for biased signalling in the P2Y receptor family of GPCRs

British Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk, Simon Pitchford, Graham Ladds   +2 more
wiley   +1 more source

Combining thiopurine with partial enteral nutrition promotes complete mucosal healing in pediatric Crohn's disease. [PDF]

Pediatr Int
Kaji E, Yoden A, Namba T, Nishimoto S, Otani M, Okuhira T, Inoue K, Aomatsu T, Nishioka D, Ashida A.   +9 more
europepmc   +1 more source